4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-060292
Pres&Chief Investment Officer acquired 71,365 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh Pres&Chief Investment Officer | 2023-12-27 | Option exercise | +71,365 | 3,289,115 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh Pres&Chief Investment Officer | 2023-12-27 | Option exercise · Capped Value Appreciation Rights | −159,100 | $6.40 | $1,018,240 | 1,856,163 | D: show line 2 in the form | |||
| Sukhatme Mayukh Pres&Chief Investment Officer | 2023-12-27 | Option exercise · Capped Value Appreciation Rights | −28,411 | $11.50 | $326,727 | 1,306,889 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…